1. Home
  2. KELYB vs VALN Comparison

KELYB vs VALN Comparison

Compare KELYB & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kelly Services Inc. Class B

KELYB

Kelly Services Inc. Class B

HOLD

Current Price

$17.96

Market Cap

551.2M

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$5.17

Market Cap

536.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KELYB
VALN
Founded
1946
2012
Country
United States
France
Employees
4900
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
551.2M
536.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
KELYB
VALN
Price
$17.96
$5.17
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$15.50
AVG Volume (30 Days)
2.5K
31.5K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
1.95%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$0.72
N/A
Revenue Next Year
N/A
$93.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.38
$5.06
52 Week High
$125.00
$12.25

Technical Indicators

Market Signals
Indicator
KELYB
VALN
Relative Strength Index (RSI) 47.30 36.83
Support Level $11.84 $5.11
Resistance Level $18.11 $6.60
Average True Range (ATR) 0.98 0.25
MACD -0.19 -0.05
Stochastic Oscillator 27.77 10.45

Price Performance

Historical Comparison
KELYB
VALN

About KELYB Kelly Services Inc. Class B

Kelly Services Inc is a specialty talent solutions company. The company operates through three reportable segments: i) Enterprise Talent Management, which provides temporary staffing, outsourcing, and permanent placement services across industrial, contact center, and clerical roles, ii) Science, Engineering & Technology, which supplies specialized talent across multiple industries, and iii) Education, which delivers staffing, placement, and executive search services to Pre-K-12 school districts and education organizations in the United States. The majority of the company's revenue is derived from the Enterprise Talent Management segment. Geographically, it generates the maximum revenue from the United States, followed by Europe and the Asia-Pacific Region.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: